Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter

Virology

Volumn 313, Issue 1, 2003, Pages 235-249

  Machado, Alexandre Vieira ^a   Naffakh, Nadia ^a   Van Der Werf, Sylvie ^a   Escriou, Nicolas ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Chloramphenicol acetyltransferase; Dicistronic; Influenza A virus; Neuraminidase; Promoter; Subgenomic RNA; Transfectant virus; Viral vector

Indexed keywords

GENE PRODUCT; MESSENGER RNA; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN; CONTROLLED STUDY; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENOME; IN VIVO STUDY; INFLUENZA; INFLUENZA VIRUS; MALE; MENGO VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA SYNTHESIS; VIRAL GENETICS; VIRUS RECOMBINANT; VIRUS REPLICATION;

INFLUENZA A VIRUS; INFLUENZA VIRUS; MENGO VIRUS;

EID: 0042388786     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00289-7     Document Type: Article

References (52)

1. Azzeh M., Flick R., Hobom G. Functional analysis of the influenza A virus cRNA promoter and construction of an ambisense transcription system. Virology. 289:(2):2001;400-410.
2. Bergmann M., Muster T. Mutations in the nonconserved noncoding sequences of the influenza A virus segments affect viral vRNA formation. Virus Res. 44:(1):1996;23-31.
3. Beyer W.E., Palache A.M., de Jong J.C., Osterhaus A.D. Cold-adapted live influenza vaccine versus inactivated vaccine systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis . Vaccine. 20:(9-10):2002;1340-1353.
4. Castrucci M.R., Bilsel P., Kawaoka Y. Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase. J. Virol. 66:(8):1992;4647-4653.
5. Castrucci M.R., Kawaoka Y. Biologic importance of neuraminidase stalk length in influenza A virus. J. Virol. 67:(2):1993;759-764.
6. Chen W., Calvo P.A., Malide D., Gibbs J., Schubert U., Bacik I., Basta S., O'Neill R., Schickli J., Palese P., Henklein P., Bennink J.R., Yewdell J.W. A novel influenza A virus mitochondrial protein that induces cell death. Nat. Med. 7:(12):2001;1306-1312.
7. Crescenzo-Chaigne B., Naffakh N., van der Werf S. Comparative analysis of the ability of the polymerase complexes of influenza viruses type A, B and C to assemble into functional RNPs that allow expression and replication of heterotypic model RNA templates in vivo. Virology. 265:(2):1999;342-353.
8. Crescenzo-Chaigne B., van der Werf S., Naffakh N. Differential effect of nucleotide substitutions in the 3′ arm of the influenza A virus vRNA promoter on transcription/replication by avian and human polymerase complexes is related to the nature of PB2 amino acid 627. Virology. 303:(2):2002;240-252.
9. Duhaut S., Dimmock N.J. Approximately 150 nucleotides from the 5′ end of an influenza A segment 1 defective virion RNA are needed for genome stability during passage of defective virus in infected cells. Virology. 275:(2):2000;278-285.
10. Duhaut S.D., Dimmock N.J. Defective segment 1 RNAs that interfere with production of infectious influenza A virus require at least 150 nucleotides of 5′ sequence evidence from a plasmid-driven system . J. Gen. Virol. 83:(Pt.2):2002;403-411.
11. Duke G.M., Palmenberg A.C. Cloning and synthesis of infectious cardiovirus RNAs containing short, discrete Poly(C) tracts. J. Virol. 63:(4):1989;1822-1826.
12. Ferko B., Stasakova J., Sereinig S., Romanova J., Katinger D., Niebler B., Katinger H., Egorov A. Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice. J. Virol. 75:(19):2001;8899-8908.
13. Flick R., Hobom G. Transient bicistronic vRNA segments for indirect selection of recombinant influenza viruses. Virology. 262:(1):1999;93-103.
14. Flick R., Neumann G., Hoffmann E., Neumeier E., Hobom G. Promoter elements in the influenza vRNA terminal structure. RNA. 2:(10):1996;1046-1057.
15. Fodor E., Palese P., Brownlee G.G., Garcia-Sastre A. Attenuation of influenza A virus mRNA levels by promoter mutations. J. Virol. 72:(8):1998;6283-6290.
16. Fosmire J.A., Hwang K., Makino S. Identification and characterization of a coronavirus packaging signal. J. Virol. 66:(6):1992;3522-3530.
17. Garcia-Sastre A., Muster T., Barclay W.S., Percy N., Palese P. Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus. J. Virol. 68:(10):1994;6254-6261.
18. Garcia-Sastre A., Percy N., Barclay W., Palese P. Introduction of foreign sequences into the genome of influenza A virus. Dev. Biol. Stand. 82:1994;237-246.
19. Gonzalo R.M., Rodriguez D., Garcia-Sastre A., Rodriguez J.R., Palese P., Esteban M. Enhanced CD8+ T cell response to HIV-1 env by combined immunization with influenza and vaccinia virus recombinants. Vaccine. 17:(7-8):1999;887-892.
20. Gubareva L.V., Bethell R., Hart G.J., Murti K.G., Penn C.R., Webster R.G. Characterization of mutants of influenza A virus selected with the neuraminidase inhibitor 4-guanidino-Neu5Ac2en. J. Virol. 70:(3):1996;1818-1827.
21. Inglis S.C., Barrett T., Brown C.M., Almond J.W. The smallest genome RNA segment of influenza virus contains two genes that may overlap. Proc. Natl. Acad. Sci. USA. 76:(8):1979;3790-3794.
22. Kolykhalov A.A., Feinstone S.M., Rice C.M. Identification of a highly conserved sequence element at the 3′ terminus of hepatitis C virus genome RNA. J. Virol. 70:(6):1996;3363-3371.
23. Krug R.M., Broni B.A., Bouloy M. Are the 5′ ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs? Cell. 18:(2):1979;329-334.
24. Lamb R.A., Choppin P.W. Segment 8 of the influenza virus genome is unique in coding for two polypeptides. Proc. Natl. Acad. Sci. USA. 76:(10):1979;4908-4912.
25. Lamb R.A., Krug R.M. Orthomyxoviridae The viruses and their replication . Fields B.N., Knipe D.M., Howley P.M., et al. Virology. 3rd ed:2001;1353-1395 Lippincott-Raven, Philadelphia.
26. Lamb R.A., Lai C.J., Choppin P.W. Sequences of mRNAs derived from genome RNA segment 7 of influenza virus colinear and interrupted mRNAs code for overlapping proteins . Proc. Natl. Acad. Sci. USA. 78:(7):1981;4170-4174.
27. Li S., Rodrigues M., Rodriguez D., Rodriguez J.R., Esteban M., Palese P., Nussenzweig R.S., Zavala F. Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc. Natl. Acad. Sci. USA. 90:(11):1993;5214-5218.
28. Luo G.X., Luytjes W., Enami M., Palese P. The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure. J. Virol. 65:(6):1991;2861-2867.
29. Luytjes W., Krystal M., Enami M., Pavin J.D., Palese P. Amplification, expression, and packaging of foreign gene by influenza virus. Cell. 59:(6):1989;1107-1113.
30. McKnight K.L., Lemon S.M. Capsid coding sequence is required for efficient replication of human rhinovirus 14 RNA. J. Virol. 70:(3):1996;1941-1952.
31. Neumann G., Hobom G. Mutational analysis of influenza virus promoter elements in vivo. J. Gen. Virol. 76:(Pt 7):1995;1709-1717.
32. Neumann G., Kawaoka Y. Generation of influenza A virus from cloned cDNAs-historical perspective and outlook for the new millenium. Rev. Med. Virol. 12:(1):2002;13-30.
33. Neumann G., Zobel A., Hobom G. RNA polymerase I-mediated expression of influenza viral RNA molecules. Virology. 202:(1):1994;477-479.
34. Odagiri T., Tashiro M. Segment-specific noncoding sequences of the influenza virus genome RNA are involved in the specific competition between defective interfering RNA and its progenitor RNA segment at the virion assembly step. J. Virol. 71:(3):1997;2138-2145.
35. Ortega J., Martin-Benito J., Zurcher T., Valpuesta J.M., Carrascosa J.L., Ortin J. Ultrastructural and functional analyses of recombinant influenza virus ribonucleoproteins suggest dimerization of nucleoprotein during virus amplification. J. Virol. 74:(1):2000;156-163.
36. Palese P., Compans R.W. Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA) mechanism of action . J. Gen. Virol. 33:(1):1976;159-163.
37. Parvin J.D., Moscona A., Pan W.T., Leider J.M., Palese P. Measurement of the mutation rates of animal viruses influenza A virus and poliovirus type 1 . J. Virol. 59:(2):1986;377-383.
38. Percy N., Barclay W.S., Garcia Sastre A., Palese P. Expression of a foreign protein by influenza A virus. J. Virol. 68:(7):1994;4486-4492.
39. Pleschka S., Jaskunas R., Engelhardt O.G., Zurcher T., Palese P., Garcia-Sastre A. A plasmid-based reverse genetics system for influenza A virus. J. Virol. 70:(6):1996;4188-4192.
40. Poon L.L., Pritlove D.C., Fodor E., Brownlee G.G. Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template. J. Virol. 73:(4):1999;3473-3476.
41. Pritlove D.C., Poon L.L., Fodor E., Sharps J., Brownlee G.G. Polyadenylation of influenza virus mRNA transcribed in vitro from model virion RNA templates requirement for 5′ conserved sequences . J. Virol. 72:(2):1998;1280-1286.
42. Robertson J.S. 5′ and 3′ terminal nucleotide sequences of the RNA genome segments of influenza virus. Nucleic Acids Res. 6:(12):1979;3745-3757.
43. Rodrigues M., Li S., Murata K., Rodriguez D., Rodriguez J.R., Bacik I., Bennink J.R., Yewdell J.W., Garcia-Sastre A., Nussenzweig R.S. Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. J. Immunol. 153:(10):1994;4636-4648.
44. Schulman J.L., Palese P. Virulence factors of influenza A viruses WSN virus neuraminidase required for plaque production in MDBK cells . J. Virol. 24:(1):1977;170-176.
45. Solorzano A., Zheng H., Fodor E., Brownlee G.G., Palese P., Garcia-Sastre A. Reduced levels of neuraminidase of influenza A viruses correlate with attenuated phenotypes in mice. J. Gen. Virol. 81:(Pt 3):2000;737-742.
46. Stech J., Xiong X., Scholtissek C., Webster R.G. Independence of evolutionary and mutational rates after transmission of avian influenza viruses to swine. J. Virol. 73:(3):1999;1878-1884.
47. Suarez-Lopez P., Ortin J. An estimation of the nucleotide substitution rate at defined positions in the influenza virus haemagglutinin gene. J. Gen. Virol. 75:(Pt. 2):1994;389-393.
48. Takasuka N., Enami M., Itamura S., Takemori T. Intranasal inoculation of a recombinant influenza virus containing exogenous nucleotides in the NS segment induces mucosal immune response against the exogenous gene product in mice. Vaccine. 20:(11-12):2002;1579-1585.
49. Troutt A.B., McHeyzer-Williams M.G., Pulendran B., Nossal G.J. Ligation-anchored PCR a simple amplification technique with single-sided specificity . Proc. Natl. Acad. Sci. USA. 89:(20):1992;9823-9825.
50. Weiss B., Geigenmuller-Gnirke U., Schlesinger S. Interactions between Sindbis virus RNAs and a 68 amino acid derivative of the viral capsid protein further defines the capsid binding site. Nucleic Acids Res. 22:(5):1994;780-786.
51. Zheng H., Palese P., Garcia-Sastre A. Nonconserved nucleotides at the 3′ and 5′ ends of an influenza A virus RNA play an important role in viral RNA replication. Virology. 217:(1):1996;242-251.
52. Zhou Y., Konig M., Hobom G., Neumeier E. Membrane-anchored incorporation of a foreign protein in recombinant influenza virions. Virology. 246:(1):1998;83-94.